NEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILURE
| dc.contributor.author | Sayfutdinova Z.A | |
| dc.date.accessioned | 2025-12-31T15:39:01Z | |
| dc.date.issued | 2024-03-28 | |
| dc.description.abstract | Hepatotoxicity is damage caused by exposure to a drug or nonpharmacological agents. Risk factors include: individual intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors. [1–3] Although most lipophilic drugs can cause hepatotoxicity , [4] antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants are the pharmacological groups that are the most common causes. [1, 5-9]. Among the drugs administered intravenously, antibiotics and neoplasia drugs are mostly associated with liver toxicity | |
| dc.format | application/pdf | |
| dc.identifier.uri | https://scholarexpress.net/index.php/wbph/article/view/3985 | |
| dc.identifier.uri | https://asianeducationindex.com/handle/123456789/49692 | |
| dc.language.iso | eng | |
| dc.publisher | Scholar Express Journals | |
| dc.relation | https://scholarexpress.net/index.php/wbph/article/view/3985/3390 | |
| dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
| dc.source | World Bulletin of Public Health; Vol. 32 (2024): WBPH; 157-161 | |
| dc.source | 2749-3644 | |
| dc.subject | Hepatotoxicity | |
| dc.subject | intolerance | |
| dc.subject | age | |
| dc.subject | gender | |
| dc.title | NEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILURE | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | Peer-reviewed Article |
item.page.files
item.page.filesection.original.bundle
pagination.showing.detail
loading.default
- item.page.filesection.name
- za_2024_new_approaches_in_the_treatment_of_metab.pdf
- item.page.filesection.size
- 223.24 KB
- item.page.filesection.format
- Adobe Portable Document Format